# Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers

> **NCT04795414** · — · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 1370 (estimated)

## Conditions studied

- SARS-CoV-2 Infection
- Covid19

## Interventions

- **BIOLOGICAL:** SARS-CoV-2 Vaccine(Vero Cell), Inactivated

## Key facts

- **NCT ID:** NCT04795414
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-14
- **Primary completion:** 2022-04-30
- **Final completion:** 2023-01-31
- **Target enrollment:** 1370 (ESTIMATED)
- **Last updated:** 2021-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04795414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04795414, "Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04795414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*